Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Context Therapeutics Inc. is a biopharmaceutical company focused on developing T cell engaging bispecific antibodies for solid tumors. Its pipeline includes candidates targeting CLDN6, MSLN, and Nectin-4, aiming to activate T cells against cancers with high unmet needs. The company leverages proprietary technologies, collaborates with partners, and relies on third-party manufacturing to develop targeted immunotherapies for global oncology markets.
This description was generated via AI from an annual report. Updated about 1 year ago.